Search Results - "Starke, R. J."

Refine Results
  1. 1

    Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children by Cruz, A. T., Starke, J. R.

    “…SETTING: Children's Tuberculosis Clinic, Houston, Texas.OBJECTIVE: To describe adherence to and tolerability of 4 months of rifampicin (4RMP) compared to 9…”
    Get full text
    Journal Article
  2. 2

    Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis by Cameron, LH, Peloquin, CA, Hiatt, P, Mann, M, Starke, JR, Faircloth, J, McNeil, JC, Patel, A, Ruiz, F

    Published in Journal of cystic fibrosis (01-03-2022)
    “…•Clofazimine (CLOF) use for pediatric non-tuberculous mycobacterial (NTM) infections is increasing.•The optimal dosing of CLOF in children (with and without…”
    Get full text
    Journal Article
  3. 3

    Twice-weekly therapy for children with tuberculosis infection or exposure by Cruz, A. T., Starke, J. R.

    “…SETTING: Children's tuberculosis clinic, Houston, TX, United States.OBJECTIVE: To determine the safety, adherence and efficacy of intermittent directly…”
    Get full text
    Journal Article
  4. 4

    A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis by HESSELING, A. C, SCHAAF, H. S, GIE, R. P, STARKE, J. R, BEYERS, N

    “…SETTING: The diagnosis of tuberculosis (TB) in children is seldom confirmed, and is based mainly on clinical signs, symptoms and special investigations…”
    Get full text
    Journal Article
  5. 5

    Requirements for the clinical evaluation of new anti-tuberculosis agents in children by Donald, P. R., Ahmed, A., Burman, W. J., Cotton, M. F., Graham, S. M., Mendel, C., McIlleron, H., Mac Kenzie, W. R., Nachman, S., Schaaf, H. S., Starke, J. R., Wingfield, C., Hesseling, A. C.

    “…The ultimate goal of evidence-based drug treatment is to produce a desired pharmacological response in a predictable manner and also to minimise adverse…”
    Get full text
    Journal Article
  6. 6

    Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding by Ikeda, S., Cruz, A. T., Starke, J. R.

    “…BACKGROUND: Childhood TB cases can be found using passive case finding (PCF), i.e., by diagnosing children presenting with symptoms, or using active case…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics of ethambutol in children and adults with tuberculosis by ZHU, M, BURMAN, W. J, JARESKO, G. S, PELOQUIN, C. A, STARKE, J. R, STAMBAUGH, J. J, STEINER, P, BULPITT, A. E, ASHKIN, D, AUCLAIR, B, BERNING, S. E, JELLIFFE, R. W

    “…SETTING: Five hospitals in the United States.OBJECTIVE: To describe ethambutol pharmacokinetics in children and adults with active tuberculosis (TB).DESIGN:…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinical features, diagnosis, and treatment of tuberculosis in infants by VALLEJO, J. G, ONG, L. T, STARKE, J. R

    Published in Pediatrics (Evanston) (01-07-1994)
    “…Despite the recent resurgence of tuberculosis among children in the United States, no series of infants < 1 year of age with tuberculosis has been reported in…”
    Get full text
    Journal Article
  10. 10

    Detection of Mycobacterium tuberculosis in clinical specimens from children using a polymerase chain reaction by SMITH, K. C, STARKE, J. R, EISENACH, K, ONG, L. T, DENBY, M

    Published in Pediatrics (Evanston) (01-02-1996)
    “…We evaluated the usefulness of the polymerase chain reaction (PCR) using the insertion sequence IS6110 as the target for DNA to detect Mycobacterium…”
    Get full text
    Journal Article
  11. 11

    Controversies in tuberculous infection among pediatric infectious disease specialists in North America by Cruz, A. T., Hersh, A. L., Starke, J. R., Beekmann, S. E., Polgreen, P. M., Banerjee, R.

    “…OBJECTIVE: To evaluate the extent to which advancements in the diagnosis and treatment of latent tuberculous infection (LTBI) have been integrated into…”
    Get full text
    Journal Article
  12. 12

    Field Efficacy Assessment of Transgenic Roundup Ready Wheat by Zhou, H., Berg, J. D., Blank, S. E., Chay, C. A., Chen, G., Eskelsen, S. R., Fry, J. E., Hoi, S., Hu, T., Isakson, P. J., Lawton, M. B., Metz, S. G., Rempel, C. B., Ryerson, D. K., Sansone, A. P., Shook, A. L., Starke, R. J., Tichota, J. M., Valenti, S. A.

    Published in Crop science (01-05-2003)
    “…Herbicide tolerant crops provide farmers access to a new weed control option of nonselective herbicide such as Roundup1 A wheat transgenic event 33391 was…”
    Get full text
    Journal Article
  13. 13

    Tuberculosis in the pediatric population of Houston, Texas by STARKE, J. R, TAYLOR-WATTS, K. T

    Published in Pediatrics (Evanston) (01-07-1989)
    “…From September 1984 to December 1987, the children's tuberculosis clinic in Houston, TX, cared for 110 children with active tuberculosis. The median age was 24…”
    Get full text
    Journal Article
  14. 14

    Tuberculosis. An old disease but a new threat to the mother, fetus, and neonate by Starke, J R

    Published in Clinics in perinatology (01-03-1997)
    “…Tuberculosis is the leading infectious disease in the world. In developing countries and certain areas of industrialized countries, rates of tuberculosis are…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Modern approach to the diagnosis and treatment of tuberculosis in children by Starke, J R

    Published in The Pediatric clinics of North America (01-06-1988)
    “…Tuberculosis in children remains an important infectious disease in the United States, with 1261 cases reported in 1985. The percentage of extrapulmonary…”
    Get more information
    Journal Article
  17. 17
  18. 18

    A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia by STARKE, J. R, EDWARDS, M. S, LANGSTON, C, BAKER, C. J

    Published in Pediatric research (01-12-1987)
    “…A mouse model of chronic pulmonary infection with either Pseudomonas aeruginosa or Pseudomonas cepacia was developed to compare bacteriologic and pathologic…”
    Get full text
    Journal Article
  19. 19

    Pharmacokinetics of Amphotericin B in Infants and Children by Starke, Jeffrey R., Mason, Edward O., Kramer, William G., Kaplan, Sheldon L.

    Published in The Journal of infectious diseases (01-04-1987)
    “…The pharmacokinetics of amphotericin B (AmB) have not previously been evaluated in children. Five very small, premature infants and five older children…”
    Get full text
    Journal Article
  20. 20